- Visibility 228 Views
- Downloads 23 Downloads
- Permissions
- DOI 10.18231/j.ijcbr.2019.097
-
CrossMark
Assessment of interrelationship between vitamin D status, thyroid stimulating hormone levels, insulin resistance and secretion in patients with subclinical hypothyroidis
Abstract
Objective: To study the relationship between thyroid stimulating hormone levels, 25 hydroxycholecalciferol (Vitamin D3) and Insulin resistance and secretion in subclinical hypothyroidism
Materials and Methods: The study population was divided into two groups, Group I include 4 0 subjects diagnosed with subclinical hypothyroidism and Group II includes 40 ages matched healthy euthyroid control group. Serum Thyroid stimulation hormone, Vitamin D3 (25-Hydroxycholecalciferol) were analyzed by Electrochemiluminisence immune assay. Insulin resistance and insulin secretion were calculated from fasting glucose and fasting insulin by Homeostasis model assessment HOMA IR and HOMA B.
Results: In subclinical hypothyroidism Serum Thyroid stimulation hormone levels and Insulin resistance were elevated(p<0.001) significantly compared to euthyroids(p<0.001). Serum Vitamin D3 (25-Hydroxycholecalciferol) and insulin secretion(HOMA B) (p<0.05) were decreased significantly compared to euthyroids. Vitamin D3 (25-Hydroxycholecalciferol) is negatively correlated with TSH and Insulin resistance (P<0.001). TSH is positively correlated with insulin resistance.(P<0.001).
Conclusion: Subclinical hypothyroidism is associated with a decreased vitamin D and insulin secretion and increased insulin resistance. This prompts us to question whether prevalence of vitamin D deficiency in Subclinical hypothyroidism, predisposes to early development of diabetes especially where both diabetes and hypothyroidism are highly prevalent. Both Insulin resistance and Vitamin D3 deficiency in subclinical hypothyroidism together lead to early development of insulin resistance disorders, metabolic syndrome and cardiovascular diseases.
Introduction
Thyroid dysfunction, diabetes mellitus and vitamin D deficiency are widely prevalent around the globe and in India. According to international diabetes federation, the number of diabetes patients expected to increase from 415 million to 642 million by 2040, India having 69.1 million patients among them.[1] Similarly, studies have shown that around 42 million people in India suffer with thyroid diseases.[2] Subclinical hypothyroidism is the most prevalent thyroid disorder affecting 3-15% of adult population,[3] eventually a substantial number of patients with Subclinical hypothyroidism develop into overt hypothyroidism at a rate of 4.3 to 8% with a high predisposition among adult population.[4],[5],[6] On the other hand vitamin D deficiency is increasing world wide ranging from 80–90% still becomes the most underdiagnosed and untreated nutritional deficiency in the world.[7],[8] Vitamin D deficiency is drawing much attention in its association with various diseases including cancer, cardiovascular diseases, autoimmune diseases, endocrine and metabolic diseases.[9],[10] Vitamin D function as an immunomodulator, its deficiency may affect autoimmune thyroid disease. Subclinical hypothyroidism associated with increased TSH and normal T3 and T4, most commonly is an early stage of hypothyroidism may be caused due to chronic autoimmune thyroiditis, which eventually develop to overt hypothyroidism each year at a rate of 4.3–8%.[4],[5],[6]
Vitamin D deficiency, hypothyroidism and diabetes mellitus are widely prevalent in India and across the world, In the present work we tried to study the association between Subclinical hypothyroidism, vitamin D deficiency and insulin resistance, whether they had any significant impact in the early predisposition of diabetes mellitus and overthypothyroidism.
Materials and Methods
Across-sectional study was carried in two groups
Inclusion criteria
In the group I, 40 clinically diagnosed patients of subclinical hypothyroidism, presenting with normal T3, T4 and increased TSH levels were included. In Group II, 40 apparently heathy euthyroid individuals were included. Inform consent was obtained from all the patients.
Exclusion criteria
Patients suffering from chronic or systemic illness that alter thyroid functional tests were excluded from the study. Alcoholics, chronic smokers & patients already on treatment for hypothyroidism were also excluded from the study. None of the patients are on vitamin D supplements.
The study was performed in Department of Biochemistry. Shadan Institute of Medical Sciences, Teaching Hospital and Research Centre, Hyderabad.
Collection of the blood sample
Under aseptic conditions, Fasting blood sample (5 ml) was drawn from antecubital veins of all the subjects. 4 ml of the blood sample was transferred into plain vacutainer was allowed to clot for 30 minutes and then centrifuged at 2000 rpm for 15 minutes for clear separation of serum.1ml fasting blood samples are collected in fluoride vacutainers for glucose estimation. Serum was taken for the analysis of T3, T4 and Thyroid stimulating hormone, Insulin, Vitamin D (25 hyroxy cholecalciferol).
Insulin, T3, T4, Thyroid stimulating hormone and Vitamin D (25 hydroxycholecalciferol) were measured by Electro Chemiluminisence Immune Assay (E CLIA) method, in Cobase 411 auto analyser and glucose by glucose oxidase and peroxides (GOD-POD) method. HOMA IR and HOMA B were calculated from fasting sugar and fasting insulin levels. HOMA IR=fasting insulin (μIU/ml) multiplied by fasting glucose (mmol/L) divided by 22.5 and HOMA B=20 multiplied by fasting insulin (μIU/ml)-3.5 divided by fasting glucose (mmol/L).[11],[12],[13]
Results
On Pearson correlation of the parameters between the health control group and sub clinical hypothyroidism we found significant (<0.001) increase in serum TSH and HOMA IR and significant (<0.001) decrease in Vitamin D3 (25 hydroxy cholecalciferol) in subclinical hypothyroidism compared to the normal healthy control group. There is significant (< 0.05) decrease in HOMA B in subclinical hypothyroidism.
In subclinical hypothyroidism, Vitamin D3 (25 hydroxy cholecalciferol) is negatively correlated with thyroid stimulating hormone and HOMA IR. Indicating increase in both HOMA IR (insulin resistance) and TSH levels in vitamin D deficiency. Similarly, we found significant positive correlation between TSH and HOMA IR. Results indicating both subclinical hypothyroid and vitamin D deficiency independently contribute the development of insulin resistance.
| Parameter | Control | Subclinical hypothyroidism | Significance (p<0.05) |
| NUMBER | 40 | 40 | |
| AGE in years | 39±6 | 37±8 | |
| SEX(m/f) | 20/20 | 16/24 | |
| TSH(µIU/mL) | 2.286 ± 1.3852 | 7.3+ 0.65 | <0.001 |
| Vitamin D3 (µIU/mL) | 40.68 ± 11.60 | 18.42 ± 4.11 | <0.001 |
| HOMA IR | 1.7831± .632 | 3.102±1.050 | <0.001 |
| HOMA B | 176.90 ±76.209 | 150± 56.209 | <0.05 |
Discussion
Thyroid and insuilin resistance
Thyroid hormones play an important role in carbohydrate metabolism by stimulating hepatic gluconeogenesis, glycogenolysis and upregulating the expression of glucose transporters (GLUT-4) and phosphoglycerate kinase. Thus facilitating glucose uptake and utilisation in peripheral tissues, acting synergistically to insulin.[14],[15],[16],[17]
Studies found high prevalence of thyroid diseases in patients with diabetes indicating possible interrelationship between thyroid status and insulin resistance. In our study we tried to observe insulin resistance in subclinical hypothyroidism. In comparison to diverse studies indicating significant impact of thyroid hormones on insulin resistance and secretion, in our study we tried to observe insulin resistance and secretion in subclinical hypothyroidism. Our search in the literature found some of the studies showing the interrelationship between thyroid hormones and its affecton insulin resistance, In a study by E. Maratou et al[18] on the levels of GLUT 3 and GLUT 4 glucose transporters on the monocyte plasmamembrane observed decreased insulin stimulated glucose transport in monocytes from patients with subclinical hypothyroidism and overt hypothyroidism due to impaired translocation of GLUT-4 glucose transporters on the plasma membrane. They suggested that if these findings in monocytes reflect respective changes in peripheral tissues, it can lead to impairment in insulin-stimulated rates of glucose disposal in muscle and adipose tissue in patients with HO and SHO, which is accounted for by impaired translocation of GLUT4 transporters on the cell surface. AL Sayed et al[19] and Tuzcu A et al[20] in their studies on subclinical hypothyroidism found only significant increase in insulin levels, but no significant change was found in insulin resistance. Lekakis et al[21] stated that flow mediated endothelial vasodilation in impaired in hypothyroid which leads to insulin resistance. In another study by Kim et al[22] from their study stated that thyroid hormones and insulin have synergistic role in glucose homeostasis at both cellular and molecular level. They hypothesised that reduced intracellular content of thyroid hormones, impairs insulin stimulated glucose uptake, hence mild decrease in thyroid hormones in subclinical hypothyroidism inversely correlated with insulin resistance. Teixeirass et al[23] from their invitro studies reveal that triiodothyronine(T3) rapidly increases glucose uptake in L6 GLUT4 muscle cells without increasing the surface GLUT4, GLUT1 and GLUT3, they proposed that rapid action of triiodothyronine(T3) is due to activation of GLUT4 transporters at the cell surface. Some other studies indicated that even a small increase in plasma TSH levels with in normal range can affect insulin secretion and may cause insulin resistance, in contrast to this in another study[24] on euthyroids, we found significant positive correlation between TSH and insulin secretion but no significant change was found in insulin resistance within normal range of TSH. In our study HOMA-IR was significantly higher in SCH when compared with euthyroid. A positive correlation was observed for TSH with HOMA IR, similar to studies by Abdel-Gayoum AA[25] where subclinical hypothyroidism associated with increasing insulin resistance, positively correlating with TSH.
Thyroid and Vitamin D
Recent studies have shown that, In addition to the maintenance of homeostasis of bone and mineral metabolism, Vitamin D, deficiency has been associated in the pathogenesis of many diseases like cancer, diabetes, heart diseases, infections and hypothyroidism.[26],[27] In the skin 7 dehydrocholesterol get converted to cholecalciferol, which get hydroxylated in the liver to 25 hydroxycholecalciferol, which has a long half-life of 15 days. 25 hydroxycholecalciferol gets hydroxylated in the kidneys forming functional vitamin D3 calcitriol (1,25 dihydroxy cholecalciferol). Calcitriol has a short half-life of 15 days and its levels in the blood are regulated by Parathormone, calcium and phosphorous.[28],[29] Calcitriol levels do not usually decrease until severe vitamin D deficiency.[30],[31] Therefore serum concentrations of 25 hydroxycholecalciferol are considered as a good indicator of vitamin D status in the body. Hence in the present study we measured 25 hydroxycholecalciferol. Though some studies have shown the association between hypothyroid and vitamin D deficiency, scanty literature is available correlating whether vitamin D deficiency leads to hypothyroidism or hypothyroidism itself a causative factor for the development of vitamin D deficiency.
In the present study we observed that vitamin D had a role to play in subclinical hypothyroidism. In this study, the subclinical hypothyroid patients had significantly lower levels of serum 25 hydroxycholecalciferol as compared to controls (p <0.001). We found a negative correlation of serum 25 hydroxycholecalciferol levels with TSH in subclinical hypothyroid patients on Pearson’s correlation analysis (r= -0.35, p<0.001), our results similar to other studies has good correlation with Thyroid stimulation hormone and vitamin D. Similar to our study, Byran Richards[32] from their experimental study on the thyroid gland found that deficiency of the vitamin D was a causative factor for low thyroid hormones, Friedman T.C[33] from his study found that a different vitamin D receptor predisposes to autoimmune diseases including hashimotos thyroiditis and graves disease. Shilpa et al[34] study on Indian population found significant relationship between hypothyroidism and vitamin D, Afsaneh et al[35] in their study on hypothyroid patients with vitamin D deficiency found improvement in thyroid function after vitamin D supplementation, indicating possible role of vitamin D in thyroid function. In addition, in hypothyroid patients decreased levels of the vitamin D might be due to poor absorption of the vitamin D from intestines or impairment in the activation of the vitamin D.
Conversely, few studies have focused on the effect of hypothyroidism on the synthesis of the vitamin D in the body, leading to vitamin D deficiency. Vitamin D Metabolism inturn is regulated by the thyroid hormones. In keratinocytes located in the basal and spinous strata of the epidermis layer 7-dehydrocholesterol is converted to Provitamin D3.[36] Thyroid hormone exerts important effects on skin. In a study by Safer JD[37] in hypothyroid patients found changes indicative of epidermal thinning and hyperkeratosis on histologic examination of the skin. Suggesting, probable impaired epidermal barrier function in hypothyroidism, speculating decreased synthesis of vitamin D.
In comparison to earlier studies indicating high prevalence of vitamin D deficiency, as a contributing factor for the development of hypothyroidism, Safer JD[37] from their study indicates prevalence of hypothyroidism itself can lead to vitamin D deficiency.
Vitamin D and insulin resistance
Benetti E et al in their study in mice found negative correlation between the vitamin D and insulin resistance.[38] Anastassios G, in their study found vitamin D supplementation in type1 and type 2 diabetes improved insulin sensitivity associated with decreased blood glucose and HbA1c levels, further suggesting higher concentration of the vitamin D are associated with subsequent decrease in cardiovascular diseases, type 2 diabetes mellitus and metabolic syndrome.[39]
Maestro B et al[40] in their study, when treated human promonocytic cells with 1,25
Dihydroxycholecalciferol for 24 hours, found transcriptional activation of human insulin receptor gene associated with improved insulin sensitivity, indicating the possible role of vitamin D on insulin resistance. Influence of the vitamin D on glucose homeostasis can be explained by the presence of specific vitamin D receptors on pancreatic beta cells and also the expression of 1α-hydroxylase in the pancreatic beta cells, indicating extra renal synthesis of vitamin D in the pancreas. It was even found the presence of the vitamin D receptors in the skeletal muscle, which activates insulin receptor gene and upregulates the expression of insulin receptors leading to insulin mediated uptake of glucose.[41],[42],[43],[44],[45],[46],[47]
There is compelling evidence between the vitamin D and its effect on insulin sensitivity and secretion in animal and invitro studies. Studies[48],[49] in mice with mutation in vitamin D receptor found with increased insulin resistance and impaired insulin secretion. Vitamin D receptor is expressed in both adipose tissue and human skeletal muscle, which are the main sites of peripheral insulin sensitivity. It was found that with increase in age there was significant decrease in the expression of vitamin D receptor associated with increase in insulin resistance.[50]
Vitamin D deficiency may also result in the elevation of PTH, [51] which inturn elevates intracellular calcium which may inhibit insulin target cells from sensing the brisk intracellular calcium fluxes necessary for insulin action.[52],[53],[54],[55] Even Increased intracellular calcium enhances calmodulin binding to IRS-1, which interferes with insulin stimulated tyrosine phosphorylation and PI3-kinase activation leading to increased insulin resistance.[56],[57],[58] In contrast Kamycheraetal[59] did not find any significant difference in insulin action in secondary hyperparathyroidism compared with the control group. In another study by Prasanjitetal,[60] on adipocytes cultured from murine adipocytes cultured from murine 3T3LI fibroblast cell line, when treated with high glucose in the presence and absence of 1,25 dihydroxycholecalciferol, found significant upregulation of GLUT 4 protein expression, translocation to cell surface and increase in glucose uptake, Indicating by which vitamin D can upregulate GLUT4 and increase glucose uptake.
Conclusion
We found that significant decrease in the vitamin D, independently affecting insulin sensitivity and secretion can lead to the early predisposition of insulin resistance associated disorders diabetes mellitus and metabolic syndrome.
Subclinical hypothyroidism initial phase of hypothyroid ism, if untreated might have a significant influence on insulin resistance and secretion that might potentiate the insulin resistance and pathogenesis of diabetes mellitus.
If untreated Hypovitaminosis D and subclinical hypothyroidism together can become a potential factor that might potentiate the pathogenesis of diseases associated with insulin resistance, including diabetes mellitus, cardiovascular diseases and metabolic syndrome.
Acknowledgments
Our acknowledgment to all the participants of our work. The authors have no conflicts of interest to disclose.
Source of funding
None.
Conflict of interest
None.
References
- . Diabetes Federation. IDF Diabetic Atlas 7th Edition. . 2016. [Google Scholar]
- Unnikrishnan AG, Menon UV. Thyroid disorders in India: An epidemiological perspective. Indian J Endocrinol Metab. 2011;15(Suppl2). [Google Scholar] [Crossref]
- Ayala AR, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinol Metab Clin N Am. 2000;29:399-415. [Google Scholar]
- Szabolcs I, Podoba J, Feldkamp J. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long term iodine prophylaxis and abundant iodine intake. Clin Endocrinol. 1997;47:87-87. [Google Scholar]
- . Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8:457-469. [Google Scholar]
- Parle JV, Franklyn JA, Cross KW. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the UK. Clin Endocrinol (Oxf). 1991;34:77-77. [Google Scholar]
- Schoor NMv, Lips P. Worldwide Vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25:671-680. [Google Scholar]
- Mithal A, Wahl DA, JPB, Burckhardt P, Dawson-Hughes B, Eisman JA. Global Vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807-1820. [Google Scholar]
- Mackawy AM, Al-Ayed BM, Al-Rashidi BM. Vitamin D deficiency and its association with thyroid disease. Int J Health Sci (Qassim). 2013;7:267-275. [Google Scholar]
- Vilrrasa N, Vendrell J, Maravall J, Elo I, Solano E, Jos PS. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?. Endocrine. 2010;38:235-242. [Google Scholar]
- Song Y, Manson JE, Tinker L, Howard VB, Lewis H, Kuller. Insulin sensitivity and insulin secretion determined by Homeostasis Model Assessment and risk of Diabetes in a multiethnic cohart of women: the womens health initiative obsevational study. Diabetes Care. 2007;30:1747-1752. [Google Scholar]
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Homeostasis Model Assessment: Insulin resistence and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. [Google Scholar]
- Ramesh J, Shaik MI, Srivalli J. Impact of Iron Indices, Mitochondrial Oxidative Capacity, Oxidative Stress and Inflammatory Markers on Insulin Resistance and Secretion: A Pathophysiologic Perspective. J Diabetes Metab. 2012;3:222-222. [Google Scholar]
- Sugden MC, Liu YL, Holness MJ. Glucose utilization by skeletal muscles in vivo in experimental hyperthyroidism in the rat. Biochem J. 1990;271:421-425. [Google Scholar]
- Chen-Zion M, Bassukevitz Y, Beitner R. Rapid changes in carbohydrate metabolism in muscle induced by triiodothyronine; the role of glucose 1,6-biphosphate. Biochem Mol Med. 1995;56:19-25. [Google Scholar]
- Casla A, Rovira A, Wells JA, Dohm GL. Increased glucose transporter (GLUT4) protein expression in hyperthyroidism. Biochem Biophys Res Commun. 1990;171:182-188. [Google Scholar]
- Shimizu Y, Shimazu T. Thyroid hormone augments GLUT4 expression and insulin-sensitive glucose transport system in differentiating rat brown adipocytes in culture. J Vet Med Sci. 2002;64:677-681. [Google Scholar]
- Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol. 2009;160:785-790. [Google Scholar]
- Al A, Nadia A, Abbas Y. Subclinical hypothyroidism is associated with insulin resistance in Kuwaiti women. Endocrine journal. 2006;53(5):653-657. [Google Scholar]
- Tuzcu A, Bahceci M, Gokalp D. Subclinical hypothyroidism may be associated with elevated high sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J. 2005;52:89-94. [Google Scholar]
- Lekakis J, Papamichael C, Alevizaki M. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high normal serum thyrotrophic (TSH) values. Thyroid. 1997;7. [Google Scholar]
- Kim SR, Tull ES, Talbott EO. A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis. Medical Hypotheses. 2002;59:660-666. [Google Scholar]
- . Silvania Silva Teixeira Triiodothyronine Acutely Stimulates Glucose Transport into L6 Muscle Cells Without Increasing Surface GLUT4, GLUT1, or GLUT3. Thyroid. 2012;22:747-754. [Google Scholar]
- . Correlation study between body mass index, body fat, glycemic indices and lipid profile with insulin resistence and secretion in healthy euthyroid individuals. Int Jo Clin Biochem Res. 2018;5(1):101-105. [Google Scholar]
- Abdel-Gayoum AA. The effect of hypothyroidism on insulin sensitivity and their influence on the serum lipid profile and renal function. Endocrinol Metab Syndr. 2016;5. [Google Scholar]
- Vilarrasa N, Vendrell J, Maravall J, Elo I, Solano E, Jos PS. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?. Endocrine. 2010;38:235-242. [Google Scholar]
- MMackawy A, Al-Ayed BM, Al-Rashidi BM. Vitamin D deficiency and its association with thyroid disease. Int J Health Sci (Qassim). 2013;7:267-275. [Google Scholar]
- . Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press. 2010. . . [Google Scholar]
- Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88:582-586. [Google Scholar]
- Elizabeth A, Brule D, Cindy D, Krista A, Peter WF, Friedl EK. Dietary Reference Intakes for vitamin D: justification for a review of the 1997 values. Am J Clin Nutr. 2009;89(3):719-727. [Google Scholar]
- Wolpowitz D, Gilchrest BS. The vitamin D questions: How much do you need and how should you get it?. J Am Acad Dermatol. 2006;54(2):301-317. [Google Scholar]
- Byron R. Health news. Low Vitamin D Contributes to Thyroid Problems. 2008. [Google Scholar]
- Theodore CF. Vitamin D Deficiency and Thyroid Disease. . . [Google Scholar]
- Bhardwaj SH, Mishra B, Yadav S, Malik E, Jain A. Vitamin D Levels Correlated With Hypothyroidism In Indian Population: A Pilot Study. Int J Recent Sci Res Res. 2014;5(5):984-987. [Google Scholar]
- Talaei A, Ghorbani F, Asemi Z. The effects of Vitamin D supplementation on thyroid function in hypothyroid patients: A randomized, double-blind, placebo-controlled trial. Indian J Endocr Metab. 2019;22:584-588. [Google Scholar]
- Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347(1-2):80-89. [Google Scholar]
- Safer JD. Thyroid hormone action on skin. Dermatoendocrinol. 2011;3(3):211-215. [Google Scholar]
- Benetti E, Mastrocola R, Chiazza F, Nigro D, D'Aantona G, Bordano V. Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese ;mice. PLoS ONE. ;13(1). [Google Scholar] [Crossref]
- . Pittas and bess dawson-hughes. Vitamin D and Diabetes. J Steroid Biochem Mol Biol. 2010;121(1-2):425-429. [Google Scholar]
- Maestro B, Davila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulinreceptor gene promoter. J Steroid Biochem Molecular Biol. 2003;84(2-3):223-230. [Google Scholar]
- Pittas AG, Lau J, Hu FB, Dawson-Hughes B. Therole of vitamin D and calcium in type 2 diabetes. A systematicreview and meta-analysis. J Clin Endocrinologyand Metab. 2007;92(6):2017-2029. [Google Scholar]
- Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267(3):356-360. [Google Scholar]
- Bland R, Markovic D, Hills CE. Expression of25-hydroxyvitamin D3-1-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004. [Google Scholar]
- Maestro B, Davila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84(2-3):223-230. [Google Scholar]
- Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities inmuscle. J Biological Chem. 1985;260(15):8882-8891. [Google Scholar]
- Maestro B, Molero S, Bajo S, D´avila N, Calle C. Transcriptional activation of the human insulin receptorgene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct. 2002;20(3):227-232. [Google Scholar]
- Maestro B, Campion J, Davila N, Calle C. Stimulationby 1,25-dihydroxyvitamin D3 of insulin receptor expressionand insulin responsiveness for glucose transport in U-937human promonocytic cells. Endocr J. 2000;47(4):383-391. [Google Scholar]
- Bischoff HA, Borchers M, Gudat F. In situ detectionof 1,25-dihydroxyvitamin D3 receptor in human skeletalmuscle tissue. Histochem J. 2001;33(1):19-24. [Google Scholar]
- Norman AW. Minireview: vitamin D receptor: new assignmentsfor an already busy receptor. Endocrinol. 2006;147(12):5542-5548. [Google Scholar]
- Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. Vitamin D receptor expressionin human muscle tissue decreases with age. J Boneand Mineral Res. 2004;19(2):265-269. [Google Scholar]
- Holick MF. Medical progress: vitamin D deficiency. New Engl J Medi. 2007;357(3):266-281. [Google Scholar]
- Reusch JEB, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 phosphorylation by intracellularcalcium in adipocytes. Endocrinol. 1991;129(6):3269-3273. [Google Scholar]
- Worrall DS, Olefsky JM. The effects of intracellularcalcium depletion on insulin signaling in 3T3-L1 adipocytes. Mol Endocrinol. 2002;16(2):378-389. [Google Scholar]
- Wollheim CB, Sharp GW. Regulation of insulin releaseby calcium. Physiol Rev. 1981;61(4):914-973. [Google Scholar]
- Bjorklund A, Lansner A, Grill VE. Glucose-induced[Ca2+](i) abnormalities in human pancreatic islets: importantrole of overstimulation. Diabetes. 2000;49(11):1840-1848. [Google Scholar]
- Zemel MB. Nutritional and endocrine modulation of intracellularcalcium: implications in obesity, insulin resistance andhypertension. Mol Cell Biochemis. 1998;188(1-2):129-136. [Google Scholar]
- Munshi HG, Burks DJ, Joyal JL, White MF, Sacks DB. Ca2+ regulates calmodulin binding to IQ motifs in IRS-1. Biochem. 1996;35(49):15883-15889. [Google Scholar]
- Li Z, Joyal JL, Sacks DB. Binding of IRS proteinsto calmodulin is enhanced in insulin resistance. Biochem. 2000;39(17):5089-5096. [Google Scholar]
- Kamycheva E, Jorde R, Figenschau Y, Haug E. Insulinsensitivity in subjects with secondary hyperparathyroidismand the effect of a low serum 25-hydroxyvitamin D level oninsulin sensitivity. J Endocrinol Investig. 2007;30(2):126-132. [Google Scholar]
- Manna P, Jain SK. Vitamin D Up-regulates Glucose Transporter 4 (GLUT4) Translocation and Glucose Utilization Mediated by Cystathionine-γ-lyase (CSE) Activation and H2S Formation in 3T3L1 Adipocytes*. J Biol Chem. 2012;287(50):42324-42332. [Google Scholar]